Chewy, Inc. CFO David Reeder Discusses Company Growth, Strategic Initiatives, and Future Outlook at JPMorgan Global Technology, Media and Communications Conference

Key Takeaways

TL;DR: Chewy (CHWY) reaffirms low SD active customer growth and +80bps adj. EBITDA margin expansion (to 5.5%) in FY25, driven by healthcare verticals (+1,000bps GM), vet clinic expansion (8–10 new clinics), automation (30%↑ fulfillment productivity), and a path to 10% LT EBITDA margins. $950M FY24 buybacks highlight robust FCF conversion (80% of EBITDA). Key focus: healthcare (30% of sales), Chewy+ membership (early traction), and tariff impacts ($10M EPS headwind).


1. Profitability & Margins

2. Growth Drivers

3. Healthcare & Vet Ecosystem

4. Capital Allocation

5. Macro & Risks